Compare NetFlix Inc (NFLX) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetFlix Inc vs GeneDx Holdings Corp — how do they compare? NetFlix Inc trades at $77.37 (market cap $309.01B), while GeneDx Holdings Corp trades at $81.94 (market cap $2.45B). The key difference: NetFlix Inc is far larger — about 126.1× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, NetFlix Inc nearer its low. Which is the better fit depends on your goals.
| NFLX | WGS | |
|---|---|---|
Market Cap | $309.01B | $2.45B |
Sector | Consumer Cyclical | Technology |
52-Week High | $126.33 | $167.51 |
52-Week Low | $67.60 | $34.51 |
Enterprise Value | $314.19B | $2.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Netflix (NFLX) trades at $74.79, down 1.97% amid a recent losing streak, yet maintains strong fundamentals with 28.22% net margins and consistent earnings beats. The stock shows bullish technical signals with support at $72-$74 levels, while analyst consensus remains positive with a $90.45 price target. Revenue growth accelerated to $45.18B in 2025, supported by expanding ad-tier adoption and content investments.
Investment outlook remains favorable given Netflix's dominant streaming position and ad revenue potential, though risks include increased competition and execution challenges in new initiatives. Wall Street's 63% buy rating reflects confidence in the company's ability to maintain growth momentum despite recent price weakness.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
